Zurich Cantonal Bank’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
37,472
+5,850
| +18% | +$253K | ﹤0.01% | 969 |
|
|
2025
Q1 | $1.09M | Buy |
31,622
+92
| +0.3% | +$3.18K | ﹤0.01% | 1113 |
|
|
2024
Q4 | $865K | Buy |
31,530
+6,466
| +26% | +$177K | ﹤0.01% | 1278 |
|
|
2024
Q3 | $638K | Sell |
25,064
-8
| -0% | -$204 | ﹤0.01% | 1407 |
|
|
2024
Q2 | $635K | Buy |
25,072
+3,122
| +14% | +$79.1K | ﹤0.01% | 1322 |
|
|
2024
Q1 | $679K | Buy |
21,950
+1,320
| +6% | +$40.8K | ﹤0.01% | 1285 |
|
|
2023
Q4 | $833K | Buy |
20,630
+3,139
| +18% | +$127K | ﹤0.01% | 1177 |
|
|
2023
Q3 | $461K | Hold |
17,491
| – | – | ﹤0.01% | 1449 |
|
|
2023
Q2 | $301K | Buy |
17,491
+3,356
| +24% | +$57.7K | ﹤0.01% | 1674 |
|
|
2023
Q1 | $234K | Hold |
14,135
| – | – | ﹤0.01% | 1771 |
|
|
2022
Q4 | $108K | Buy |
14,135
+4,038
| +40% | +$30.8K | ﹤0.01% | 2222 |
|
|
2022
Q3 | $100K | Hold |
10,097
| – | – | ﹤0.01% | 2223 |
|
|
2022
Q2 | $92K | Hold |
10,097
| – | – | ﹤0.01% | 2300 |
|
|
2022
Q1 | $102K | Sell |
10,097
-838
| -8% | -$8.47K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $182K | Buy |
10,935
+2,900
| +36% | +$48.3K | ﹤0.01% | 2126 |
|
|
2021
Q3 | $377K | Sell |
8,035
-10
| -0.1% | -$469 | ﹤0.01% | 1479 |
|
|
2021
Q2 | $490K | Buy |
8,045
+3,050
| +61% | +$186K | ﹤0.01% | 1238 |
|
|
2021
Q1 | $308K | Buy |
+4,995
| New | +$308K | ﹤0.01% | 1527 |
|